Detail your involvement
2
Liminatus Pharma to go public via a SPAC merger with Arrow Capital-backed Iris Acquisition in a $334m deal.
Service Providers
pr advisors
Trequartista Consulting
or
Principals
bidder
IRIS ACQUISITION CORP
bidder
ARROW CAPITAL PARTNERS
target
LIMINATUS PHARMA
Principals or Service Provider not listed?Add missing Service Provider or Principal
All rights reserved. Copyright © 2025 Datasite